1	NEW	new	JJ	p2=NNP	2	nn	_
2	YORK	york	NNP	p2=NN	30	nn	_
3	,	,	,	_	2	punct	_
4	May	may	NNP	_	59	nn	_
5	19	0	CD	_	4	num	_
6	,	,	,	_	20	punct	_
7	2014	0	CD	_	12	num	_
8	/	/	SYM	p2=,	12	punct	_
9	PRNewswire	prnewswire	NNP	p2=NN	12	nn	_
10	/	/	SYM	_	12	punct	_
11	--	--	:	_	12	punct	_
12	Novocure	novocure	NNP	p2=UH	20	nsubj	20:A0=PAG
13	,	,	,	_	12	punct	_
14	a	a	DT	_	18	det	_
15	commercial	commercial	JJ	_	16	amod	_
16	stage	stage	NN	_	18	nn	_
17	oncology	oncology	NN	p2=IN	18	nn	_
18	company	company	NN	_	12	appos	_
19	,	,	,	_	12	punct	_
20	announced	announce	VBD	pb=announce.01	0	root	_
21	today	today	NN	_	20	npadvmod	20:AM-TMP
22	that	that	IN	_	38	complm	_
23	an	an	DT	_	24	det	_
24	analysis	analysis	NN	_	30	nn	_
25	of	of	IN	_	24	prep	_
26	the	the	DT	_	27	det	_
27	efficacy	efficacy	NN	_	25	pobj	_
28	and	and	CC	_	27	cc	_
29	safety	safety	NN	_	27	conj	_
30	data	datum	NNS	_	38	nsubjpass	38:A1=PRD
31	from	from	IN	_	30	prep	_
32	its	its	PRP$	_	35	poss	_
33	U.S.	u.s.	NNP	_	35	nn	_
34	patient	patient	NN	p2=JJ	35	nn	_
35	registry	registry	NN	_	31	pobj	_
36	will	will	MD	_	38	aux	38:AM-MOD
37	be	be	VB	_	38	auxpass	_
38	published	publish	VBN	pb=publish.01	20	ccomp	20:A1=PPT
39	as	as	IN	_	38	prep	38:AM-PRD
40	part	part	NN	_	39	pobj	_
41	of	of	IN	_	40	prep	_
42	the	the	DT	_	47	det	_
43	50	0	CD	_	47	num	_
44	(	(	-LRB-	_	47	punct	_
45	th	th	NN	p2=UH	47	nn	_
46	)	)	-RRB-	_	47	punct	_
47	meeting	meeting	NN	p2=VBG	41	pobj	_
48	of	of	IN	_	47	prep	_
49	the	the	DT	_	51	det	_
50	American	american	NNP	p2=JJ	51	nn	_
51	Society	society	NNP	_	48	pobj	_
52	of	of	IN	_	51	prep	_
53	Clinical	clinical	JJ	p2=NNP	54	amod	_
54	Oncology	oncology	NNP	p2=NN	52	pobj	_
55	(	(	-LRB-	_	56	punct	_
56	ASCO	asco	NNP	_	54	appos	_
57	)	)	-RRB-	_	56	punct	_
58	in	in	IN	_	54	prep	_
59	Chicago	chicago	NNP	_	58	pobj	_
60	,	,	,	_	54	punct	_
61	IL	il	NN	p2=NNP	12	appos	_
62	from	from	IN	_	61	prep	_
63	May	may	NNP	_	62	pobj	_
64	30	0	CD	p2=NNP	63	num	_
65	-	-	:	p2=SYM	63	punct	_
66	June	june	NNP	_	62	npadvmod	_
67	3	0	CD	_	66	num	_
68	,	,	,	_	66	punct	_
69	2014	0	CD	_	66	num	_
70	.	.	.	_	20	punct	_

1	The	the	DT	_	4	det	_
2	U.S.	u.s.	NNP	_	4	nn	_
3	patient	patient	NN	p2=JJ	4	nn	_
4	registry	registry	NN	p2=VBD	5	nsubj	5:A2=GOL
5	included	include	VBD	pb=include.01	0	root	_
6	data	datum	NNS	p2=NN	5	dobj	5:A1=PPT
7	for	for	IN	_	6	prep	_
8	all	all	DT	p2=PDT	11	det	_
9	recurrent	recurrent	JJ	p2=NN	11	amod	_
10	glioblastoma	glioblastoma	NN	p2=NNP	11	nn	_
11	patients	patient	NNS	_	7	pobj	12:A1=PPT
12	treated	treat	VBN	p2=VBD|pb=treat.02	11	partmod	_
13	with	with	IN	_	12	prep	12:A2=GOL
14	NovoTTF	novottf	NNP	_	15	nn	_
15	Therapy	therapy	NNP	_	13	pobj	_
16	from	from	IN	_	12	prep	12:AM-TMP
17	October	october	NNP	_	16	pobj	_
18	2011	0	CD	_	17	num	_
19	to	to	IN	_	12	prep	_
20	November	november	NNP	_	19	pobj	_
21	2013	0	CD	_	20	num	_
22	at	at	IN	_	12	prep	12:AM-LOC
23	91	0	CD	_	26	num	_
24	leading	lead	VBG	p2=NN|pb=lead.01	26	amod	_
25	oncology	oncology	NN	p2=IN	26	nn	_
26	centers	center	NNS	_	22	pobj	24:A0=PAG
27	in	in	IN	_	26	prep	_
28	the	the	DT	_	30	det	_
29	United	united	NNP	_	30	nn	_
30	States	states	NNP	_	27	pobj	_
31	(	(	-LRB-	_	30	punct	_
32	n=457	n=457	NNP	p2=RB	30	appos	_
33	)	)	-RRB-	_	30	punct	_
34	.	.	.	_	5	punct	_

1	"	"	``	_	6	punct	_
2	Data	data	NNP	p2=NN	6	nsubj	10:A0=CAU;6:A1=PPT
3	from	from	IN	_	2	prep	_
4	this	this	DT	_	5	det	_
5	registry	registry	NN	_	3	pobj	_
6	are	be	VBP	pb=be.01	0	root	_
7	very	very	RB	_	8	advmod	_
8	encouraging	encouraging	JJ	p2=VBG	6	acomp	6:A2=PRD
9	and	and	CC	_	6	cc	_
10	indicate	indicate	VBP	p2=VB|pb=indicate.01	6	conj	_
11	that	that	IN	p2=DT	15	complm	_
12	NovoTTF	novottf	NNP	p2=IN	13	nn	_
13	Therapy	therapy	NNP	_	15	nsubj	15:A1=PPT
14	may	may	MD	_	15	aux	15:AM-MOD
15	be	be	VB	pb=be.01	10	ccomp	10:A1=PPT
16	an	an	DT	_	18	det	_
17	effective	effective	JJ	_	18	amod	_
18	treatment	treatment	NN	_	15	attr	15:A2=PRD
19	for	for	IN	_	18	prep	_
20	some	some	DT	_	21	det	_
21	patients	patient	NNS	_	19	pobj	_
22	with	with	IN	_	21	prep	_
23	recurrent	recurrent	JJ	p2=NN	24	amod	_
24	glioblastoma	glioblastoma	NN	p2=NNS	22	pobj	_
25	.	.	.	_	6	punct	_

1	This	this	DT	_	2	det	_
2	therapy	therapy	NN	_	3	nsubj	3:A1=PPT;6:A1;10:A1=PPT
3	is	be	VBZ	pb=be.01	24	ccomp	24:A1=PPT
4	very	very	RB	_	5	advmod	_
5	well	well	RB	_	6	advmod	6:AM-MNR
6	tolerated	tolerate	VBN	pb=tolerate.01	3	acomp	3:A2=PRD
7	and	and	CC	_	3	cc	_
8	could	could	MD	_	10	aux	10:AM-MOD
9	be	be	VB	_	10	auxpass	_
10	offered	offer	VBN	pb=offer.01	3	conj	_
11	as	as	IN	_	10	prep	10:AM-MNR
12	a	a	DT	_	14	det	_
13	therapeutic	therapeutic	JJ	_	14	amod	_
14	option	option	NN	_	11	pobj	_
15	to	to	IN	_	14	prep	_
16	patients	patient	NNS	_	15	pobj	17:A0=PPT
17	experiencing	experience	VBG	pb=experience.01	16	partmod	_
18	recurrence	recurrence	NN	_	17	dobj	17:A1=PAG
19	of	of	IN	_	18	prep	_
20	the	the	DT	_	21	det	_
21	disease	disease	NN	_	19	pobj	_
22	,	,	,	_	24	punct	_
23	"	"	''	_	24	punct	_
24	said	say	VBD	pb=say.01	0	root	_
25	study	study	NN	p2=VB	26	nn	_
26	author	author	NN	_	30	nn	_
27	Dr.	dr.	NNP	_	30	nn	_
28	Maciej	maciej	NNP	_	30	nn	_
29	M.	m.	NNP	_	30	nn	_
30	Mrugala	mrugala	NNP	_	24	nsubj	24:A0
31	,	,	,	_	30	punct	_
32	MD	md	NNP	_	30	appos	_
33	,	,	,	_	32	punct	_
34	Ph.D	ph.d	NNP	_	32	conj	_
35	,	,	,	_	34	punct	_
36	MPH	mph	NNP	_	41	nn	_
37	Alexander	alexander	NNP	_	39	nn	_
38	M.	m.	NNP	_	39	nn	_
39	Spence	spence	NNP	_	41	nn	_
40	Endowed	endowed	NNP	p2=VBD	41	nn	_
41	Chair	chair	NNP	_	34	conj	_
42	in	in	IN	_	41	prep	_
43	Neuro	neuro	NNP	_	45	hmod	_
44	-	-	HYPH	p2=,	45	hyph	_
45	Oncology	oncology	NNP	_	42	pobj	_
46	,	,	,	_	41	punct	_
47	and	and	CC	_	41	cc	_
48	Chief	chief	NNP	_	50	nn	_
49	,	,	,	_	48	punct	_
50	Division	division	NNP	p2=NN	41	conj	_
51	of	of	IN	_	50	prep	_
52	Neuro	neuro	NNP	_	54	hmod	_
53	-	-	HYPH	p2=,	54	hyph	_
54	Oncology	oncology	NNP	_	51	pobj	_
55	,	,	,	_	54	punct	_
56	University	university	NNP	_	54	appos	_
57	of	of	IN	_	56	prep	_
58	Washington	washington	NNP	_	59	nn	_
59	School	school	NNP	_	57	pobj	_
60	of	of	IN	_	59	prep	_
61	Medicine	medicine	NNP	_	60	pobj	_
62	.	.	.	_	24	punct	_

1	"	"	``	_	4	punct	_
2	These	these	DT	_	3	det	_
3	data	datum	NNS	_	4	nsubj	4:A0=CAU
4	show	show	VBP	pb=show.01	0	root	_
5	that	that	IN	_	19	complm	_
6	in	in	IN	_	19	prep	19:AM-LOC
7	real	real	JJ	_	9	amod	_
8	life	life	NN	_	9	nn	_
9	use	use	NN	_	6	pobj	_
10	of	of	IN	_	9	prep	_
11	NovoTTF	novottf	NNP	_	12	nn	_
12	Therapy	therapy	NNP	_	10	pobj	_
13	,	,	,	_	12	punct	_
14	survival	survival	NN	_	12	appos	_
15	of	of	IN	_	14	prep	_
16	recurrent	recurrent	JJ	p2=NN	18	amod	_
17	glioblastoma	glioblastoma	NN	p2=FW	18	nn	_
18	patients	patient	NNS	_	15	pobj	_
19	is	be	VBZ	pb=be.01	4	ccomp	4:A1=PPT
20	approximately	approximately	RB	_	21	advmod	_
21	50	0	CD	_	22	num	_
22	%	%	NN	_	23	npadvmod	_
23	longer	long	JJR	p2=RB	19	acomp	19:A2=PRD
24	than	than	IN	_	23	prep	_
25	what	what	WP	_	27	nsubjpass	27:R-A1
26	was	be	VBD	_	27	auxpass	_
27	seen	see	VBN	pb=see.01	24	pcomp	_
28	in	in	IN	_	27	prep	27:AM-LOC
29	both	both	DT	_	30	det	_
30	arms	arm	NNS	_	28	pobj	_
31	(	(	-LRB-	_	38	punct	_
32	NovoTTF	novottf	NNP	p2=AFX	33	nn	_
33	therapy	therapy	NN	_	34	nn	_
34	arm	arm	NN	_	38	nn	_
35	and	and	CC	_	34	cc	_
36	chemotherapy	chemotherapy	NN	_	37	nn	_
37	control	control	NN	_	34	conj	_
38	arm	arm	NN	_	30	appos	_
39	)	)	-RRB-	_	38	punct	_
40	of	of	IN	_	38	prep	_
41	the	the	DT	_	42	det	_
42	therapy	therapy	NN	_	45	poss	_
43	's	's	POS	_	42	possessive	_
44	registration	registration	NN	_	45	nn	_
45	trial	trial	NN	_	40	pobj	_
46	.	.	.	_	4	punct	_
47	"	"	''	_	4	punct	_

1	"	"	``	p2=''	23	punct	_
2	Novocure	novocure	NNP	p2=JJ	4	nsubjpass	6:A0=PAG;4:A1=PPT
3	is	be	VBZ	_	4	auxpass	_
4	committed	commit	VBN	p2=JJ|pb=commit.01	23	ccomp	23:A1=PPT
5	to	to	IN	_	4	prep	4:A2=GOL
6	providing	provide	VBG	pb=provide.01	5	pcomp	_
7	physicians	physician	NNS	_	6	dobj	6:A1=PPT
8	and	and	CC	_	7	cc	_
9	patients	patient	NNS	_	7	conj	_
10	with	with	IN	_	6	prep	6:A2=GOL
11	the	the	DT	_	12	det	_
12	data	datum	NNS	_	10	pobj	_
13	necessary	necessary	JJ	_	12	amod	_
14	to	to	TO	_	15	aux	_
15	make	make	VB	pb=make.02	13	xcomp	_
16	informed	informed	JJ	_	17	amod	_
17	decisions	decision	NNS	_	15	dobj	15:AM-PRR
18	about	about	IN	_	17	prep	_
19	NovoTTF	novottf	NNP	_	20	nn	_
20	Therapy	therapy	NNP	_	18	pobj	_
21	,	,	,	_	23	punct	_
22	"	"	''	_	23	punct	_
23	said	say	VBD	pb=say.01	0	root	_
24	Eilon	eilon	NNP	_	25	nn	_
25	Kirson	kirson	NNP	_	23	nsubj	23:A0
26	,	,	,	_	25	punct	_
27	MD	md	NNP	_	25	appos	_
28	,	,	,	_	27	punct	_
29	Ph.D.	ph.d.	NNP	p2=NN	27	conj	_
30	,	,	,	_	29	punct	_
31	Chief	chief	NNP	_	33	nn	_
32	Science	science	NNP	_	33	nn	_
33	Officer	officer	NNP	_	29	conj	_
34	and	and	CC	_	33	cc	_
35	Head	head	NNP	_	33	conj	_
36	of	of	IN	_	35	prep	_
37	Research	research	NNP	_	36	pobj	_
38	and	and	CC	_	37	cc	_
39	Development	development	NNP	_	37	conj	_
40	at	at	IN	_	29	prep	_
41	Novocure	novocure	NNP	_	40	pobj	_
42	.	.	.	_	23	punct	_

1	"	"	``	_	8	punct	_
2	The	the	DT	_	4	det	_
3	registry	registry	NN	p2=JJ	4	nn	_
4	data	datum	NNS	p2=NN	8	nsubj	8:A0=PAG
5	of	of	IN	_	4	prep	_
6	457	0	CD	_	7	num	_
7	patients	patient	NNS	_	5	pobj	_
8	provide	provide	VBP	pb=provide.01	0	root	_
9	physicians	physician	NNS	_	8	dobj	8:A1=PPT
10	and	and	CC	_	9	cc	_
11	patients	patient	NNS	_	9	conj	_
12	with	with	IN	_	8	prep	8:AM-ADV
13	evidence	evidence	NN	_	12	pobj	_
14	to	to	TO	_	15	aux	_
15	confirm	confirm	VB	pb=confirm.01	8	advcl	_
16	that	that	IN	p2=DT	21	complm	_
17	NovoTTF	novottf	NNP	_	18	nn	_
18	Therapy	therapy	NNP	_	21	nsubjpass	21:A1=PPT
19	can	can	MD	_	21	aux	21:AM-MOD
20	be	be	VB	_	21	auxpass	_
21	used	use	VBN	pb=use.01	15	ccomp	15:A1=PPT
22	safely	safely	RB	_	21	advmod	21:AM-MNR
23	and	and	CC	_	22	cc	_
24	effectively	effectively	RB	_	22	conj	_
25	in	in	IN	_	21	prep	21:AM-LOC
26	the	the	DT	_	28	det	_
27	real	real	JJ	_	28	amod	_
28	world	world	NN	_	25	pobj	_
29	setting	set	VBG	pb=set.02	21	xcomp	_
30	outside	outside	IN	p2=JJ	29	prep	29:AM-LOC
31	clinical	clinical	JJ	_	32	amod	_
32	trials	trial	NNS	_	30	pobj	_
33	.	.	.	_	8	punct	_
34	"	"	''	_	8	punct	_

1	About	about	RB	p2=IN	4	advmod	_
2	Glioblastoma	glioblastoma	NNP	_	3	nn	_
3	Glioblastoma	glioblastoma	NNP	_	4	nsubj	4:A1=PPT
4	is	be	VBZ	pb=be.01	0	root	_
5	the	the	DT	_	8	det	_
6	most	most	RBS	_	7	advmod	_
7	common	common	JJ	_	8	amod	_
8	form	form	NN	_	4	attr	4:A2=PRD
9	of	of	IN	_	8	prep	_
10	primary	primary	JJ	_	12	amod	_
11	brain	brain	NN	_	12	nn	_
12	cancer	cancer	NN	_	9	pobj	_
13	with	with	IN	_	8	prep	_
14	approximately	approximately	RB	_	15	advmod	_
15	10,000	0	CD	_	16	num	_
16	patients	patient	NNS	_	13	pobj	17:A1=PPT
17	diagnosed	diagnose	VBD	p2=VBN|pb=diagnose.01	16	partmod	_
18	each	each	DT	_	19	det	_
19	year	year	NN	_	17	npadvmod	17:AM-TMP
20	in	in	IN	_	17	prep	17:A2=PRD
21	the	the	DT	_	23	det	_
22	United	united	NNP	_	23	nn	_
23	States	states	NNP	_	20	pobj	_
24	.	.	.	_	4	punct	_

1	The	the	DT	_	2	det	_
2	disease	disease	NN	_	4	nsubjpass	4:A1=PPT
3	is	be	VBZ	_	4	auxpass	_
4	known	know	VBN	pb=know.01	0	root	_
5	as	as	IN	_	11	mark	_
6	recurrent	recurrent	JJ	p2=FW	7	amod	_
7	glioblastoma	glioblastoma	NN	p2=FW	5	pobj	_
8	when	when	WRB	_	11	advmod	11:R-AM-TMP;13:R-AM-TMP
9	the	the	DT	_	10	det	_
10	tumor	tumor	NN	_	11	nsubj	11:A1=PAG;13:A1=ADV
11	progresses	progress	VBZ	pb=progress.01	4	advcl	4:AM-TMP
12	or	or	CC	_	11	cc	_
13	recurs	recur	VBZ	p2=NNS|pb=recur.01	11	conj	_
14	after	after	IN	_	13	prep	13:AM-TMP
15	initial	initial	JJ	_	16	amod	_
16	treatment	treatment	NN	_	14	pobj	_
17	.	.	.	_	4	punct	_

1	Overall	overall	RB	p2=JJ	2	amod	_
2	survival	survival	NN	p2=RB	10	nsubjpass	10:A1
3	from	from	IN	_	2	prep	_
4	the	the	DT	_	5	det	_
5	time	time	NN	_	3	pobj	_
6	of	of	IN	_	5	prep	_
7	recurrence	recurrence	NN	_	6	pobj	_
8	has	have	VBZ	_	10	aux	_
9	been	be	VBN	_	10	auxpass	_
10	reported	report	VBN	pb=report.01	0	root	_
11	at	at	IN	_	10	prep	10:AM-TMP
12	3-5	0	CD	_	13	num	_
13	months	month	NNS	_	11	pobj	_
14	without	without	IN	_	13	prep	_
15	active	active	JJ	_	16	amod	_
16	treatment	treatment	NN	_	14	pobj	_
17	.	.	.	_	10	punct	_

1	About	about	RB	p2=IN	18	advmod	_
2	the	the	DT	_	10	det	_
3	NovoTTF	novottf	NNP	_	5	hmod	_
4	-	-	HYPH	_	5	hyph	_
5	100A	100a	NNP	_	10	nn	_
6	System	system	NNP	_	10	nn	_
7	NovoTTF	novottf	NNP	_	9	hmod	_
8	-	-	HYPH	_	9	hyph	_
9	100A	100a	NNP	_	10	nn	_
10	System	system	NNP	_	1	pobj	_
11	is	be	VBZ	_	18	auxpass	_
12	a	a	DT	_	17	det	_
13	portable	portable	JJ	_	17	amod	_
14	,	,	,	_	17	punct	_
15	non-invasive	non-invasive	JJ	_	17	amod	_
16	medical	medical	JJ	_	17	amod	_
17	device	device	NN	_	18	nsubjpass	18:A1=PRD
18	designed	design	VBN	pb=design.01	0	root	_
19	for	for	IN	_	18	prep	18:A3=PRP
20	continuous	continuous	JJ	_	21	amod	_
21	use	use	NN	_	19	pobj	_
22	by	by	IN	_	18	agent	18:A0=PAG
23	patients	patient	NNS	_	22	pobj	_
24	.	.	.	_	18	punct	_

1	In	in	IN	_	8	prep	8:AM-LOC
2	vitro	vitro	FW	p2=NN	1	pobj	_
3	and	and	CC	_	1	cc	_
4	in	in	IN	_	1	conj	_
5	vivo	vivo	JJ	p2=FW	6	amod	_
6	studies	study	NNS	_	4	pobj	_
7	have	have	VBP	_	8	aux	_
8	shown	show	VBN	pb=show.01	0	root	_
9	that	that	IN	_	15	complm	_
10	the	the	DT	_	14	det	_
11	NovoTTF	novottf	NNP	_	13	hmod	_
12	-	-	HYPH	_	13	hyph	_
13	100A	100a	NNP	_	14	nn	_
14	System	system	NNP	_	15	nsubj	17:A0=PAG;15:A1=PPT
15	slows	slow	VBZ	pb=slow.02	8	ccomp	8:A1=PPT
16	and	and	CC	_	15	cc	_
17	reverses	reverse	VBZ	pb=reverse.01	15	conj	_
18	tumor	tumor	NN	p2=JJ	19	nn	_
19	growth	growth	NN	_	17	dobj	17:A1=PPT
20	by	by	IN	_	17	prep	17:AM-MNR
21	inhibiting	inhibit	VBG	pb=inhibit.01	20	pcomp	_
22	mitosis	mitosis	NN	_	21	dobj	21:A1=PPT
23	,	,	,	_	22	punct	_
24	the	the	DT	_	25	det	_
25	process	process	NN	_	22	appos	29:AM-LOC;31:AM-LOC
26	by	by	IN	_	29	prep	29:R-AM-MNR
27	which	which	WDT	_	26	pobj	_
28	cells	cell	NNS	_	29	nsubj	29:A1=PPT;31:A1=PPT
29	divide	divide	VBP	pb=divide.02	25	rcmod	_
30	and	and	CC	_	29	cc	_
31	replicate	replicate	VBP	pb=replicate.01	29	conj	_
32	.	.	.	_	8	punct	_

1	The	the	DT	_	5	det	_
2	NovoTTF	novottf	NNP	_	4	hmod	_
3	-	-	HYPH	_	4	hyph	_
4	100A	100a	NNP	_	5	nn	_
5	System	system	NNP	p2=NN	6	nsubj	6:A0=PAG;15:A0=PAG
6	weighs	weigh	VBZ	pb=weigh.01	0	root	_
7	about	about	RB	p2=IN	8	advmod	_
8	six	#crd#	CD	_	9	num	_
9	pounds	pound	NNS	_	6	dobj	6:A3=VSP
10	(	(	-LRB-	_	9	punct	_
11	three	#crd#	CD	_	12	num	_
12	kilograms	kilogram	NNS	_	9	appos	_
13	)	)	-RRB-	_	9	punct	_
14	and	and	CC	_	6	cc	_
15	creates	create	VBZ	pb=create.01	6	conj	_
16	a	a	DT	_	18	det	_
17	low	low	JJ	_	18	amod	_
18	intensity	intensity	NN	_	15	dobj	15:A1=PPT
19	,	,	,	_	15	punct	_
20	alternating	alternate	VBG	pb=alternate.01	15	advcl	15:AM-ADV
21	electric	electric	JJ	_	22	amod	_
22	field	field	NN	_	20	dobj	20:A1=PPT
23	within	within	IN	_	20	prep	20:A2=PPT
24	a	a	DT	_	25	det	_
25	tumor	tumor	NN	_	23	pobj	27:A0=PAG
26	that	that	WDT	p2=IN	27	nsubj	27:R-A0
27	exerts	exert	VBZ	pb=exert.01	25	rcmod	_
28	physical	physical	JJ	_	29	amod	_
29	forces	force	NNS	_	27	dobj	27:A1=PPT
30	on	on	IN	_	29	prep	_
31	electrically	electrically	RB	_	32	advmod	32:AM-MNR
32	charged	charge	VBN	p2=JJ|pb=charge.05	34	amod	_
33	cellular	cellular	JJ	_	34	amod	_
34	components	component	NNS	_	30	pobj	32:A1=PPT
35	,	,	,	_	27	punct	_
36	preventing	prevent	VBG	pb=prevent.01	27	advcl	_
37	the	the	DT	_	40	det	_
38	normal	normal	JJ	_	40	amod	_
39	mitotic	mitotic	JJ	p2=NN	40	amod	_
40	process	process	NN	_	36	dobj	36:A1=PPT
41	and	and	CC	_	36	cc	_
42	causing	cause	VBG	pb=cause.01	36	conj	_
43	cancer	cancer	NN	_	44	nn	_
44	cell	cell	NN	_	45	nn	_
45	death	death	NN	_	42	dobj	42:A1=PPT
46	.	.	.	_	6	punct	_

1	In	in	IN	_	12	prep	12:AM-LOC
2	patients	patient	NNS	_	1	pobj	_
3	with	with	IN	_	2	prep	_
4	recurrent	recurrent	JJ	p2=NN	7	amod	_
5	glioblastoma	glioblastoma	NN	_	6	nn	_
6	brain	brain	NN	_	7	nn	_
7	tumors	tumor	NNS	_	3	pobj	_
8	,	,	,	_	12	punct	_
9	the	the	DT	_	10	det	_
10	system	system	NN	_	12	nsubj	12:A0=CAU
11	has	have	VBZ	_	12	aux	_
12	shown	show	VBN	pb=show.01	0	root	_
13	clinical	clinical	JJ	_	14	amod	_
14	efficacy	efficacy	NN	p2=JJ	12	dobj	12:A1=PPT
15	comparable	comparable	JJ	_	14	amod	_
16	to	to	IN	_	15	prep	_
17	that	that	DT	_	16	pobj	_
18	of	of	IN	_	17	prep	_
19	active	active	JJ	_	20	amod	_
20	chemotherapies	chemotherapy	NNS	_	18	pobj	_
21	with	with	IN	_	20	prep	_
22	better	good	JJR	_	23	amod	_
23	quality	quality	NN	_	21	pobj	_
24	of	of	IN	_	23	prep	_
25	life	life	NN	_	24	pobj	_
26	and	and	CC	_	21	cc	_
27	without	without	IN	_	21	conj	_
28	many	many	JJ	p2=DT	27	pobj	_
29	of	of	IN	_	28	prep	_
30	the	the	DT	_	32	det	_
31	side	side	NN	p2=JJ	32	amod	_
32	effects	effect	NNS	_	29	pobj	_
33	of	of	IN	_	32	prep	_
34	chemotherapy	chemotherapy	NN	_	33	pobj	_
35	.	.	.	_	12	punct	_

1	The	the	DT	_	5	det	_
2	NovoTTF	novottf	NNP	_	4	hmod	_
3	-	-	HYPH	_	4	hyph	_
4	100A	100a	NNP	_	5	nn	_
5	System	system	NNP	_	7	nsubj	7:A0=PAG
6	has	have	VBZ	_	7	aux	_
7	received	receive	VBN	pb=receive.01	0	root	_
8	marketing	marketing	NN	p2=VBG	9	nn	_
9	approval	approval	NN	_	7	dobj	7:A1=PPT
10	in	in	IN	_	7	prep	7:AM-LOC
11	the	the	DT	_	13	det	_
12	United	united	NNP	_	13	nn	_
13	States	states	NNP	_	10	pobj	_
14	(	(	-LRB-	_	13	punct	_
15	U.S.	u.s.	NNP	_	13	appos	_
16	)	)	-RRB-	_	13	punct	_
17	and	and	CC	_	7	cc	_
18	is	be	VBZ	_	23	auxpass	_
19	a	a	DT	_	22	det	_
20	CE	ce	NNP	p2=NN	21	nn	_
21	Marked	marked	NNP	p2=VBN	22	nn	_
22	device	device	NN	_	23	nsubjpass	23:A1=PPT
23	cleared	clear	VBN	p2=VBN|pb=clear.02	7	conj	_
24	for	for	IN	_	23	prep	23:AM-PNC
25	sale	sale	NN	_	24	pobj	_
26	in	in	IN	_	25	prep	_
27	the	the	DT	_	29	det	_
28	European	european	NNP	_	29	nn	_
29	Union	union	NNP	_	26	pobj	_
30	,	,	,	_	29	punct	_
31	Switzerland	switzerland	NNP	_	29	conj	_
32	,	,	,	_	31	punct	_
33	Australia	australia	NNP	_	31	conj	_
34	and	and	CC	_	33	cc	_
35	Israel	israel	NNP	_	33	conj	_
36	.	.	.	_	23	punct	_

1	Approved	approve	VBD	p2=VBN|pb=approve.01	0	root	_
2	Indication	indication	NNP	p2=NN	4	nn	_
3	The	the	DT	p2=NNP	4	det	_
4	FDA	fda	NNP	_	6	nsubj	6:A0
5	has	have	VBZ	_	6	aux	_
6	approved	approve	VBN	pb=approve.01	1	ccomp	1:A1=PPT
7	the	the	DT	_	11	det	_
8	NovoTTF	novottf	NNP	_	10	hmod	_
9	-	-	HYPH	_	10	hyph	_
10	100A	100a	NNP	_	11	nn	_
11	System	system	NNP	_	6	dobj	6:A1=PPT
12	for	for	IN	_	6	prep	_
13	use	use	NN	_	12	pobj	_
14	as	as	IN	_	13	prep	_
15	a	a	DT	_	16	det	_
16	treatment	treatment	NN	_	14	pobj	_
17	for	for	IN	_	16	prep	_
18	adult	adult	NN	_	19	nn	_
19	patients	patient	NNS	_	17	pobj	_
20	(	(	-LRB-	_	6	punct	_
21	22	0	CD	_	22	num	_
22	years	year	NNS	_	6	npadvmod	_
23	of	of	IN	_	22	prep	_
24	age	age	NN	_	23	pobj	_
25	or	or	CC	_	22	cc	_
26	older	old	JJR	_	22	conj	_
27	)	)	-RRB-	_	6	punct	_
28	with	with	IN	_	6	prep	_
29	histologically	histologically	RB	_	31	hmod	_
30	-	-	HYPH	_	31	hyph	_
31	confirmed	confirm	VBN	_	32	amod	_
32	GBM	gbm	NNP	p2=NN	28	pobj	_
33	,	,	,	_	6	punct	_
34	following	follow	VBG	_	6	prep	_
35	histologically	histologically	RB	p2=NN	40	advmod	_
36	-	-	HYPH	p2=:	35	hyph	_
37	or	or	CC	_	35	cc	_
38	radiologically	radiologically	RB	_	40	hmod	_
39	-	-	HYPH	_	40	hyph	_
40	confirmed	confirm	VBN	_	41	amod	_
41	recurrence	recurrence	NN	_	34	pobj	_
42	in	in	IN	_	41	prep	_
43	the	the	DT	_	45	det	_
44	supra-tentorial	supra-tentorial	JJ	_	45	amod	_
45	region	region	NN	_	42	pobj	_
46	of	of	IN	_	45	prep	_
47	the	the	DT	_	48	det	_
48	brain	brain	NN	_	46	pobj	_
49	after	after	IN	_	34	prep	_
50	receiving	receive	VBG	pb=receive.01	49	pcomp	_
51	chemotherapy	chemotherapy	NN	_	50	dobj	50:A1=PPT
52	.	.	.	_	1	punct	_

1	The	the	DT	_	2	det	_
2	system	system	NN	_	4	nsubjpass	7:A1=PPT;4:A2=VSP;13:A2=VSP
3	is	be	VBZ	_	4	auxpass	_
4	intended	intend	VBN	pb=intend.01	0	root	_
5	to	to	TO	_	7	aux	_
6	be	be	VB	_	7	auxpass	_
7	used	use	VBN	pb=use.01	4	xcomp	4:A1=PPT
8	as	as	IN	_	7	prep	7:A2=PRP
9	monotherapy	monotherapy	NN	_	8	pobj	_
10	,	,	,	_	4	punct	_
11	and	and	CC	_	4	cc	_
12	is	be	VBZ	_	13	auxpass	_
13	intended	intend	VBN	pb=intend.01	4	conj	_
14	as	as	IN	_	13	prep	13:A1=PPT
15	an	an	DT	_	16	det	_
16	alternative	alternative	NN	_	14	pobj	_
17	to	to	IN	_	16	prep	_
18	standard	standard	JJ	_	20	amod	_
19	medical	medical	JJ	_	20	amod	_
20	therapy	therapy	NN	_	17	pobj	_
21	for	for	IN	_	16	prep	_
22	GBM	gbm	NNP	p2=NN	21	pobj	_
23	after	after	IN	_	30	mark	_
24	surgical	surgical	JJ	_	27	amod	_
25	and	and	CC	_	24	cc	_
26	radiation	radiation	NN	_	24	conj	_
27	options	option	NNS	_	30	nsubjpass	30:A1=PPT
28	have	have	VBP	_	30	aux	_
29	been	be	VBN	_	30	auxpass	_
30	exhausted	exhaust	VBN	p2=JJ|pb=exhaust.01	16	advcl	_
31	.	.	.	_	4	punct	_

